Literature DB >> 22760083

Arrhythmias in the muscular dystrophies.

William J Groh1.   

Abstract

The muscular dystrophies are a group of inherited diseases affecting skeletal muscle that also affect cardiac muscle. Cardiac involvement occurs as a degenerative process with fibrosis and fatty replacement of the myocardium. Electrophysiologists are asked to participate in the care of muscular dystrophy patients because of the risk of atrial arrhythmias, conduction disease, bradycardia, ventricular arrhythmias, and sudden death. Duchenne, Becker, and limb-girdle types 2C-2F and 2I are muscular dystrophies in which the development of a dilated cardiomyopathy is common. Arrhythmias and conduction disease occur after the development of the dilated cardiomyopathy. Patients are considered for pacemakers or implantable cardioverter-defibrillators on the basis of guidelines used for nonischemic cardiomyopathies. Myotonic types 1 and 2, Emery-Dreifuss, limb-girdle type 1B, and facioscapulohumeral muscular dystrophies present with conduction disease and associated arrhythmias and variably with a dilated cardiomyopathy. In myotonic type 1, Emery-Dreifuss, and limb-girdle type 1B muscular dystrophies, conduction abnormalities are frequent and often require pacing. Recent studies support the use of prophylactic implantable cardioverter-defibrillators rather than pacemakers. In all the muscular dystrophies, respiratory muscle involvement can impact quality and quantity of life and needs to be factored in when considering a prophylactic device.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22760083     DOI: 10.1016/j.hrthm.2012.06.038

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  25 in total

Review 1.  Cardiomyopathy in becker muscular dystrophy: Overview.

Authors:  Rady Ho; My-Le Nguyen; Paul Mather
Journal:  World J Cardiol       Date:  2016-06-26

Review 2.  Mechano-chemo-transduction in cardiac myocytes.

Authors:  Ye Chen-Izu; Leighton T Izu
Journal:  J Physiol       Date:  2017-03-10       Impact factor: 5.182

Review 3.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

Review 4.  Gene Editing and Gene-Based Therapeutics for Cardiomyopathies.

Authors:  Joyce C Ohiri; Elizabeth M McNally
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

5.  Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy.

Authors:  Sameer Ather; Wei Wang; Qiongling Wang; Na Li; Mark E Anderson; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2012-12-12       Impact factor: 6.343

6.  Cardiac Disease Burden and Risk of Mortality in Hospitalized Muscular Dystrophy Patients.

Authors:  Ann R Punnoose; Jonathan R Kaltman; William Pastor; Robert McCarter; Jianping He; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2016-06-17       Impact factor: 1.655

7.  Diagnostic Yield of Genetic Testing in Young Patients With Atrioventricular Block of Unknown Cause.

Authors:  Johnni Resdal Dyssekilde; Tanja Charlotte Frederiksen; Morten Krogh Christiansen; Rikke Hasle Sørensen; Lisbeth Nørum Pedersen; Peter Loof Møller; Lene Svendstrup Christensen; Jacob Moesgaard Larsen; Kristian Korsgaard Thomsen; Tommi Bo Lindhardt; Morten Böttcher; Stig Molsted; Ole Havndrup; Thomas Fischer; Dorthe Svenstrup Møller; Finn Lund Henriksen; Jens Brock Johansen; Jens Cosedis Nielsen; Henning Bundgaard; Mette Nygaard; Henrik Kjærulf Jensen
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

8.  Selective Connexin43 Inhibition Prevents Isoproterenol-Induced Arrhythmias and Lethality in Muscular Dystrophy Mice.

Authors:  J Patrick Gonzalez; Jayalakshmi Ramachandran; Lai-Hua Xie; Jorge E Contreras; Diego Fraidenraich
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.379

9.  POPDC1(S201F) causes muscular dystrophy and arrhythmia by affecting protein trafficking.

Authors:  Roland F R Schindler; Chiara Scotton; Jianguo Zhang; Chiara Passarelli; Beatriz Ortiz-Bonnin; Subreena Simrick; Thorsten Schwerte; Kar-Lai Poon; Mingyan Fang; Susanne Rinné; Alexander Froese; Viacheslav O Nikolaev; Christiane Grunert; Thomas Müller; Giorgio Tasca; Padmini Sarathchandra; Fabrizio Drago; Bruno Dallapiccola; Claudio Rapezzi; Eloisa Arbustini; Francesca Romana Di Raimo; Marcella Neri; Rita Selvatici; Francesca Gualandi; Fabiana Fattori; Antonello Pietrangelo; Wenyan Li; Hui Jiang; Xun Xu; Enrico Bertini; Niels Decher; Jun Wang; Thomas Brand; Alessandra Ferlini
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808

10.  Cardiac resynchronization therapy in a young patient with Duchenne muscular dystrophy.

Authors:  Tamami Kono; Akiyoshi Ogimoto; Kazuhisa Nishimura; Toshihiro Yorozuya; Takafumi Okura; Jitsuo Higaki
Journal:  Int Med Case Rep J       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.